Arbutus Biopharma Corporation (ABUS) is currently at $4.04, down $0.67 or 14.15%
--Would be lowest close since Sept. 4, 2025, when it closed at $4.01
--On pace for largest percent decrease since July 24, 2020, when it fell 20%
--Currently down two consecutive days; down 15.59% over this period
--Worst two day stretch since the two days ending April 25, 2023, when it fell 15.67%
--Down 12.66% this week; worst weekly performance since the week ending April 28, 2023, when it fell 16.33%
--Down 16.11% month-to-date
--Down 16.11% year-to-date
--Down 86.96% from its all-time closing high of $30.94 on March 11, 2014
--Up 26.09% from 52 weeks ago (Jan. 17, 2025), when it closed at $3.20
--Down 18.48% from its 52-week closing high of $4.95 on Dec. 15, 2025
--Up 40.1% from its 52-week closing low of $2.88 on April 8, 2025
--Traded as low as $3.68; lowest intraday level since Sept. 2, 2025, when it hit $3.66
--Down 21.7% at today's intraday low; largest intraday percent decrease since July 24, 2020, when it fell as much as 23.06%
All data as of 12:15:23 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 16, 2026 12:21 ET (17:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.